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Abstract This is the Wrst neuropathology report of a male
patient (born 1960–died 1975) with an extremely rare, atyp-
ical variant of CLN2 that has been diagnosed only in Wve
families so far. The clinical history started during his pre-
school years with relatively mild motor and psychological
diYculties, but with normal intellect and vision. Since age
six there were progressive cerebellar and extrapyramidal
symptomatology, amaurosis, and mental deterioration. Epi-
leptic seizures were absent. The child died aged 15 years in
extreme cachexy. Neuropathology revealed neurolysoso-
mal storage of autoXuorescent, curvilinear and subunit c of
mitochondrial ATP synthase (SCMAS) rich material. The
neuronal storage led to laminar neuronal depopulation in
the cerebral cortex and to a practically total eradication of
the cerebellar cortical neurons. The other areas of the cen-
tral nervous system including hippocampus, which are usu-
ally heavily aVected in classical forms of CLN2, displayed
either a lesser degree or absence of neuronal storage, or
storage without signiWcant neuronal loss. Transformation of
the stored material to the spheroid like perikaryal inclusions
was rudimentary. The follow-up, after 30 years, showed
heterozygous values of TPP1 (tripeptidylpeptidase 1)
activity in the white blood cells of both parents and the sis-
ter. DNA analysis of CLN2 gene identiWed a paternal fre-
quent null mutation c.622C > T (p.Arg208 X) in the 6th
exon and a maternal novel mutation c.1439 T > G in exon
12 (p.Val480Gly). TPP1 immunohistochemistry using a
speciWc antibody gave negative results in the brain and
other organs. Our report supports the notion that the spec-
trum of CLN2 phenotypes may be surprisingly broad. The
study revealed variable sensitivities in neuronal subpopula-
tions to the metabolic defect which may be responsible for
the variant’s serious course.
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Introduction
The family of neuronal ceroid lipofuscinoses (NCL) con-
sists, to date, of ten entities [13], two of which still resist
exact deWnition at the molecular level, while the others
have been well deWned. Three are caused by mutations of
genes coding for enzymes: cathepsin D [17, 20], palmitoyl-
protein thioesterase [23] and tripeptidylpeptidase 1 (TPP1)
[18]; in Wve the mutated gene codes for transmembrane
proteins or for soluble lysosomal proteins with unknown
functions. All the relevant information concerning the
responsible genes, mutated proteins, their structural and
functional relationship to the lysosomal system, and the
nature of the stored compounds, which are mainly proteins,
has been reviewed [9, 13, 15]. A molecular classiWcation
has replaced the former phenotype based one and uniWed
the diverse phenotypes under a single precisely deWned dis-
order [16, 22, 26]. The CLN2 phenotype is generally con-
sidered to be repetitive and uniform, well deWned by age of
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120 Acta Neuropathol (2008) 116:119–124onset (late infantile) and having speciWc neurological
symptoms and electrophysiological Wndings [24]. There are
only three reports referring to variants with protracted
courses [11, 19, 25]. This is only the fourth report of atypi-
cal CLN2 having one novel mutation in the CLN2/TPP1
gene and diVering clinically from previously published
cases with respect to the absence of epilepsy. It indicates
that the phenotypic spectrum of this type of NCL may be
unexpectedly broad. It is also the Wrst neuropathology
report showing diVerent sensitivities of various neuronal
systems to TPP1 deWciency.
Clinical history
A boy with an unremarkable family history (mother
healthy, father treated for diabetes, one healthy sister) was
born in 1960. The Wrst problem reported by his parents was
at the age of 3 years when the child experienced diYculty
in trying to run. According to the parents, the child was
quite clumsy and awkward. Nevertheless, at this age, he
was able to feed himself using cutlery. He spoke in sen-
tences, but with a clear lisp; speech therapy started at age 4.
The boy’s intellect was above average. During kindergarten
he exhibited behavioral problems and had diYculty in com-
municating with other children. He detested noise (vacuum
cleaners, washing machines) and was afraid of them. He
was unable to learn to ride a bicycle during his preschool
years. An investigation for regression of motor functions
and mental diYculties was undertaken by neurologists and
psychologists during the Wrst class of primary school; a
slight cerebral palsy with normal intellect was diagnosed.
The child’s ability to draw corresponded to the age of
3 years. At the age of 7 years, following a measles vaccina-
tion, his condition worsened. He was sent to hospital at the
age of 8 years for thorough investigations. Routine bio-
chemical tests of the blood, urine, and cerebrospinal Xuid
revealed nothing abnormal. The EEG revealed diVuse
abnormalities with a parieto-occipital maximum. Episodic
high-voltage, slow waves were induced by hyperventila-
tion. A neurologist found paleocerebellar, neocerebellar,
and extrapyramidal syndromes and dementia. Vision was 7/
18, eye grounds were normal and skull X-rays were normal.
Mental deterioration, speech, and motor diYculties pro-
gressed gradually and over time, and eventually total blind-
ness and spasticity developed. Therapy was limited to
Chlorpromazine (2 £ 10 mg) and to vitamin B12. After
several years, he became wheelchair bound and shortly
thereafter, he became bedridden. The patient never experi-
enced myoclonic or any other types of convulsions. He died
at the age of 15 years (1975) in extreme cachexia from
aspiration bronchopneumonia while residing in a social
care institution.
The autopsy revealed pronounced cerebral and cerebellar
atrophy (850 g). The substantia nigra was unpigmented.
Materials and methods
Samples of central nervous system and visceral organs
(heart, kidney, liver, spleen, and lungs) were Wxed in 10%
formalin and processed for histology and after osmiWcation
for electron microscopy. For histology, the sections were
stained using a battery of techniques used for analysis of
tissues in neuronal ceroid lipofuscinoses [4, 7, 8]. In our
review of the archived tissue samples, cathepsin D was
detected with rabbit polyclonal antibodies (DAKO, Copen-
hagen, Denmark; dilution 1:2,000 or 4,000). Subunit c of
mitochondrial ATP synthase (SCMAS) and tripeptidylpepti-
dase 1 (TPP1) enzyme protein were also detected using anti-
bodies kindly supplied by Dr. Ezaki (Juntedo University,
Tokyo, Japan). After dewaxing, the sections were incubated
with the primary antibodies (diluted 1:100–200) overnight in
the refrigerator, washed and exposed to the appropriate
Envision™+kit (DAKO, Copenhagen, Denmark).
DNA extraction from the archived paraYn blocks of pro-
band’s spleen, brain and heart was unsuccessful. Total geno-
mic DNA from proband’s parents was isolated from Ficoll
separated lymphocytes using the QIAamp Blood Mini Kit.
Total RNA was isolated from the maternal blood according
to the method described [2] with Trizol lysis (Invitrogen).
cDNA was prepared by reverse transcription using Super-
Script II Reverse Transcriptase (Invitrogen) and oligo dT18
primer (Invitrogen). The entire gene-coding region (13
exons) as well as 5 and 3 untranslated regions and exon/
intron boundaries of the CLN 2 gene were examined by
direct sequencing of PCR and RT/PCR products. Primers
for PCR were designed according to GenBank reference
sequence (NC_000011.8; NM_000391.2). PCR and RT/PCR
products were prepared using thermostable DNA polymerase
PPP Master Mix (Top Bio) and puriWed on 1% agarose gel
by Wizard SV Gel and PCR clean-up System (Promega).
PCR products were used as a template for cycle sequencing
on capillary sequencer (ABI 3100-Avant Genetic Analyzer).
TPP1 activity was measured in leukocytes Xuorimetri-
cally using the synthetic substrate Ala-Ala-Phe-7-amido-4-
methylcoumarin (Sigma A3401) accordingly [28].
Results
Storage process
Regardless of cell types, storage was characterized by
accumulation of autoXuorescent granules, and for the most
part, was maximally expressed in central neurons which123
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ocks which, on occasion, were remarkably distended. The
storage frequently led to neuronal regression and loss (see
below). There were strong signals for SCMAS and for
cathepsin D. The deposits displayed uniform curvilinear
ultrastructure with variable admixture of dense homoge-
nous droplet like deposits; no Wngerprints were observed.
Infrequently, the neuronal storage lysosomes displayed
fusion with transformation of the stored material, a process
which has been shown to exist, to variable degrees in other
NCL types and is characterized by altered staining,
absence of detectable SCMAS and electron densiWcation
[4, 8]. It was accompanied by either reduced or absent
cathepsin D signals. The process was expressed in some of
the nigral neurons but to a low degree and was rarely seen
in locations typical of the classical late infantile CLN2
variants [4].
Storage distribution
Neuronal storage in the brain neocortex was uniform and
was expressed in layers II, III, IV and VI, layer I being
unaVected while layer V was severely depleted of neurons,
severely astrogliosed and inWltrated by CD68 positive
microglial phagocytes containing autoXuorescent storage
granules (Fig. 1a). Layer V was also somewhat spongy in
appearance. Other cortical layers displayed a lesser degree
of astrogliosis. Neuronal storage in the entorhinal cortex
had a similar distribution with moderate neuronal depletion
in layers II and IV, and was expressed in all transitional
Welds of the hippocampal formation (parasubiculum,
praesubiculum), as well as in the subiculum, although,
without signiWcant neuronal reduction. In the hippocampal
Welds CA1–CA4, neuronal storage was restricted to the
stratum pyramidale with decreasing order from CA1 to
CA4. In both CA3 and CA4 Welds it was restricted to
isolated neurons. There were discrete storage granules in the
dentate gyrus neurons. The cerebellar cortex was depleted
of the majority of its neurons in all layers and massively
astrogliosed (Fig. 1b). There were only exceptional persisting
Purkinje cells, which were loaded with storage granules.
The dentate nucleus exhibited neuronal storage and only
mild neuronal loss.
Neurons in the thalamus and in the basal ganglia dis-
played variable degrees of storage with questionable signs
of regression and loss. Large striatal neurons displayed bor-
derline storage (borderline autoXuorescence and borderline
SCMAS signal) and diVered from the surrounding small
and medium-sized neurons (Fig. 2a, b). In other parts of the
CNS, storage was present without signiWcant regression.
There were neurons in the oblongata and brain stem that
were either without detectable or with only borderline focal
perikaryal storage especially on the Xoor of the 4th ventri-
cle (Fig. 2c, d). In the spinal medulla, maximal storage was
found in the neurons of the posterior columns, while being
virtually absent from the bulk of the anterior horn neurons
(Fig. 2e, f). Myelin staining was not signiWcantly reduced.
The ependyma displayed discrete storage. No autoXuores-
cent granules were detectable in the choroid plexus epithe-
lium. Signs of active demyelinization were absent. CD68
positive microglial phagocytes containing autoXuorescent
SCMAS positive granules were exceptional and concen-
trated in areas of neuronal degeneration. Occasional peri-
vascular macrophages harbored lipofuscin with a nonspeciWc
ultrastructure.
Extraneuronal storage was characterized by autoXuores-
cent and SCMAS positive granules. It was observed, in
decreasing order, in cardiocytes, kidney tubules, smooth
muscle cells of visceral arteries, adipocytes, hepatocytes,
spleen (macrophages and sinusoidal endothelium), and in
vascular endothelium. Comparisons with classical CLN2
showed a major diVerence in hepatocytes, which displayed
Fig. 1 a ParaYn section of cerebral cortex showing storage conWned
to layers II, III, IV, and VI. Layer V is almost totally depleted of stor-
age neurons. SCMAS staining (bar 200 m). Insert shows detail of
perikaryal and axon hillock distension (bar 50 m). b Cerebellar cortex
with extreme depopulation of the cortical neuronal layers and pro-
nounced gliosis in the Bergmann astrocytic layer. H&E (bar 200 m)123
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somes contained curvilinear proWles. Occasionally, there
was typical lipofuscin in separate lysosomal populations
(hepatocytes, renal tubules).
TPP1 activities in both parents and sister showed typical
heterozygote values: mother 129, father 138, sister
171 nmol mg prot ¡1 h¡1 (controls: 202–482 (mean § SD
297 § 70, n = 43)).
Direct sequencing revealed that the proband’s father and
sister are carriers of frequent null mutation c.622C > T
(p.Arg208X) in the 6th exon of the CLN2 gene. In the
maternal gene a novel variation c.1439T > G in exon 12
was found. Its predicted eVect on protein structure is an
amino acid exchange of a valine for a glycine residue at
position 480 (p.Val480Gly). Sequencing of the transcript
(cDNA) showed the heterozygous substitution c.1439T > G
but did not reveal any eVect of this transversion on mRNA
splicing. Restriction analysis, using endonucleases BsrI or
ScrFI (NEB, Ipswich, MA, USA) conWrmed the substitu-
tion c.1439T > G in the mother’s gene and was negative in
300 control alleles. This result together with high phyloge-
netic conservation of valine residue in CLN2 gene, in
10 species, supports our consideration, that this missense
nucleotide change is causative. Thus the sequence variations
c.622C > T (p.Arg208X) and c.1439T > G (p.Val480Gly)
conWrm the diagnosis of cLINCL.
Discussion
Cases of CLN2 with atypical clinical manifestation are
extremely rare. So far only seven patients (in Wve families)
have been published [11, 19, 25]. Their clinical course con-
sisted of progressive loss of motor functions (extrapyrami-
dal and cerebellar signs), dementia, and in some of them
uncontrollable seizures; visual impairment was variable.
Formally the course corresponded to the juvenile pheno-
type. Dominant ultrastructure was curvilinear, but an
Fig. 2 a, b Striatum. SCMAS 
staining showing advanced stor-
age conWned to the population of 
small and middle-sized neurons. 
Large neurons display border-
line storage only. Insert in a 
shows intensive storage in the 
large neuron in typical CLN2 
(bars 30 m). c, d Medulla 
oblongata neurons, SCMAS 
staining. Variable storage inten-
sity ranging from the borderline 
to high level (bars 30 m). e, f 
Spinal medulla, SCMAS stain-
ing. Motoneurons with border-
line storage, contrasting with 
pronounced storage in posterior 
columns neurons (bars 30 m). 
Insert in a shows intense storage 
in motoneurons in classical 
CLN2 (bar 100 m)123
Acta Neuropathol (2008) 116:119–124 123admixture of other proWles was also seen. No autopsy
reports have been made available.
Our case shared both basic features of the NCL2 storage
process, i.e. the ultrastructural appearance with the uniform
curvilinear proWle pattern of the stored material [6] and the
extracerebral SCMAS storage pattern [7]. Therefore, the
original pathology report, in the late 1970s, concluded
ceroid lipofuscinosis, supposedly of the late infantile type.
The case was mentioned as atypical CLN2 in the national
report [5] due to the notably atypical clinical manifestation,
relative to classical CLN2, which is characterized by an
early, full blown onset, rapidly progressive course with Wts,
frequently of the myoclonic type, early amaurosis and ERG
extinction, EEG with a spike response to photic stimula-
tion, and death within the Wrst decade. The crucial contem-
porary electrophysiological tests were not available at that
time. The Wnal conWrmation had to wait as only recently it
has been possible to contact the family and oVer diagnosis
veriWcation using diagnostic criteria at the molecular level
[18].
The neuropathology of this variant case, published for
the Wrst time, showed signiWcant sparing and survival of
neurons in regions extensively aVected in classical CLN2
such as large striatal neurons, neurons in the medulla
oblongata and spinal alpha motor neurons [1, 3, 10] as well
as our unpublished observations (see inserts to Fig. 2a, e).
Sparing of the hippocampal neuronal population contrasted
with its complete eradication in full blown CLN2 [21]. This
indicates that brain cortical neuronal damage is more severe
in the six-layered neocortex than in the developmentally
older cortical formations which have reduced lamination
(hippocampal formation, entorhinal cortex).
The described case diVered from the typical phenotype
by the complete absence of epileptic paroxysms of any
type. Our report strengthens the evidence that the spectrum
of CLN2 phenotypes may be surprisingly broad, not only
with regard to the rate of progression but also the variability
of neurological manifestations. This in turn makes an intra-
vital diagnosis and eVective genetic counseling, based on
established clinical criteria only, extremely diYcult if even
possible.
The genotype phenotype correlation is diYcult. In our
case, the frequent null mutation (p.Arg208X) was com-
bined with the novel one (p.Val480Gly) which might be
responsible for the variant phenotype. However, the posi-
tion of the valine residue near the active center and its high
phylogenetic conservation [27] does not suggest a mutation
of a mild type. Mutation in the vicinity (p.Phe481Cys) was
described [12] without any details of the clinical phenotype.
The suggestion that the variant course described in two
patients is caused by the p.Arg447His exchange at the
highly conserved and protein stabilizing arginine residue
[27], could not be conWrmed experimentally [14]. The
genotype in the other published variant cases was also char-
acterized by mutations with heavy impact on the enzyme at
the structural level [11, 23]. These data suggest that the
explanation of the variant course, at the genotype level, is
hardly possible. We would like to emphasize that only
when this case was studied at the cellular and tissue levels,
it was possible to unravel the signiWcantly diVerent sensi-
tivity of various neuronal populations to TPP1 deWciency in
the described genotype. We, therefore, suggest that diVer-
ent degrees of aVection of brain neuronal populations may
be responsible for the variant’s serious course. We would
like to stress that neuropathology should be performed in
other variant cases as well as this approach seems to be
eVective in evaluating the given genotype/phenotype corre-
lation in individual neuronal populations.
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